Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

15

Revenue 2017

Novo Nordisk

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novo Nordisk's 2013 sales performance.

Novo Nordisk

The threat of antimicrobial resistance

The threat of antimicrobial resistance

These initiatives have been recently joined by a $165m ‘REPAIR’fund from Novo Holdings, as an investment in companies involved in discovery and early-stage development of therapies to combat antimicrobial

Novo Nordisk appoints new general manager

Novo Nordisk appoints new general manager Novo Nordisk appoints new general manager. Pinder Sahota also becomes the corporate vice president, UK. ... He said: “I am delighted to join Novo Nordisk in the role of general manager in the UK.

Novo Nordisk pays $400m for EpiDestiny’s sickle cell drug

Novo Nordisk pays $400m for EpiDestiny’s sickle cell drug Novo Nordisk pays $400m for EpiDestiny’ s sickle cell drug. The candidate is expected to start a phase II trial in the coming months. ... Novo Nordisk has bolstered its biopharma unit with a global licensing deal for a small-molecule drug for genetic

David Colpman joins Forendo Pharma’s board

David Colpman joins Forendo Pharma’s board His previous roles include head of global business development at Shire and business development and commercial positions at Glaxo Wellcome - now GlaxoSmithKline - and Novo Nordisk.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is a creative agency specialising in healthcare communication and understanding people's personality types....

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics